Norges Bank Cara Therapeutics, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$9.12 - $17.78 $455,999 - $889,000	-50,000 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$16.11 - $25.98 $805,500 - $1.3 Million	50,000 New	50,000 $806,000
Q4 2019 Feb 12, 2020	SELL	$16.11 - $25.98 $805,500 - $1.3 Million	-50,000 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$18.28 - $26.91 $914,000 - $1.35 Million	50,000 New	50,000 $914,000

797K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $857M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.